Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI-generated data contamination erodes pathological variability and diagnostic reliability
arXiv:2601.12946v1 Announce Type: cross Abstract: Generative artificial intelligence (AI) is rapidly populating medical records with synthetic content, creating a feedback loop where future models are increasingly at risk of training on uncurated AI-generated data. However, the clinical consequences of this AI-generated data contamination remain unexplored. Here, we show that in the absence of mandatory human verification, this self-referential cycle drives a rapid erosion of pathological varia
-
cs.AI, q-bio.NC updates on arXiv.org
-
From "Thinking" to "Justifying": Aligning High-Stakes Explainability with Professional Communication Standards
arXiv:2601.07233v1 Announce Type: new Abstract: Explainable AI (XAI) in high-stakes domains should help stakeholders trust and verify system outputs. Yet Chain-of-Thought methods reason before concluding, and logical gaps or hallucinations can yield conclusions that do not reliably align with their rationale. Thus, we propose "Result -> Justify", which constrains the output communication to present a conclusion before its structured justification. We introduce SEF (Structured Explainability
From "Thinking" to "Justifying": Aligning High-Stakes Explainability with Professional Communication Standards
-
cs.AI, q-bio.NC updates on arXiv.org
-
Digital Twin AI: Opportunities and Challenges from Large Language Models to World Models
arXiv:2601.01321v1 Announce Type: new Abstract: Digital twins, as precise digital representations of physical systems, have evolved from passive simulation tools into intelligent and autonomous entities through the integration of artificial intelligence technologies. This paper presents a unified four-stage framework that systematically characterizes AI integration across the digital twin lifecycle, spanning modeling, mirroring, intervention, and autonomous management. By synthesizing existing
Digital Twin AI: Opportunities and Challenges from Large Language Models to World Models
-
npj Digital Medicine
-
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
npj Digital Medicine, Published online: 26 December 2025; doi:10.1038/s41746-025-02277-8A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
npj Digital Medicine, Published online: 26 December 2025; doi:10.1038/s41746-025-02277-8
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains-
cs.AI, q-bio.NC updates on arXiv.org
-
Algorithms Trained on Normal Chest X-rays Can Predict Health Insurance Types
arXiv:2511.11030v4 Announce Type: replace-cross Abstract: Artificial intelligence is revealing what medicine never intended to encode. Deep vision models, trained on chest X-rays, can now detect not only disease but also invisible traces of social inequality. In this study, we show that state-of-the-art architectures (DenseNet121, SwinV2-B, MedMamba) can predict a patient's health insurance type, a strong proxy for socioeconomic status, from normal chest X-rays with significant accuracy (AUC ar
Algorithms Trained on Normal Chest X-rays Can Predict Health Insurance Types
-
cs.AI, q-bio.NC updates on arXiv.org
-
AutoSurvey2: Empowering Researchers with Next Level Automated Literature Surveys
arXiv:2510.26012v3 Announce Type: replace Abstract: The rapid growth of research literature, particularly in large language models (LLMs), has made producing comprehensive and current survey papers increasingly difficult. This paper introduces autosurvey2, a multi-stage pipeline that automates survey generation through retrieval-augmented synthesis and structured evaluation. The system integrates parallel section generation, iterative refinement, and real-time retrieval of recent publications t
AutoSurvey2: Empowering Researchers with Next Level Automated Literature Surveys
-
cs.AI, q-bio.NC updates on arXiv.org
-
Algorithms Trained on Normal Chest X-rays Can Predict Health Insurance Types
arXiv:2511.11030v3 Announce Type: replace-cross Abstract: Artificial intelligence is revealing what medicine never intended to encode. Deep vision models, trained on chest X-rays, can now detect not only disease but also invisible traces of social inequality. In this study, we show that state-of-the-art architectures (DenseNet121, SwinV2-B, MedMamba) can predict a patient's health insurance type, a strong proxy for socioeconomic status, from normal chest X-rays with significant accuracy (AUC ar
Algorithms Trained on Normal Chest X-rays Can Predict Health Insurance Types
-
cs.AI, q-bio.NC updates on arXiv.org
-
MirrorMind: Empowering OmniScientist with the Expert Perspectives and Collective Knowledge of Human Scientists
arXiv:2511.16997v1 Announce Type: new Abstract: The emergence of AI Scientists has demonstrated remarkable potential in automating scientific research. However, current approaches largely conceptualize scientific discovery as a solitary optimization or search process, overlooking that knowledge production is inherently a social and historical endeavor. Human scientific insight stems from two distinct yet interconnected sources. First is the individual cognitive trajectory, where a researcher's
MirrorMind: Empowering OmniScientist with the Expert Perspectives and Collective Knowledge of Human Scientists
-
cs.AI, q-bio.NC updates on arXiv.org
-
Large Language Model Benchmarks in Medical Tasks
arXiv:2410.21348v3 Announce Type: replace-cross Abstract: With the increasing application of large language models (LLMs) in the medical domain, evaluating these models' performance using benchmark datasets has become crucial. This paper presents a comprehensive survey of various benchmark datasets employed in medical LLM tasks. These datasets span multiple modalities including text, image, and multimodal benchmarks, focusing on different aspects of medical knowledge such as electronic health r
Large Language Model Benchmarks in Medical Tasks
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications
Front Immunol. 2025 Oct 14;16:1668630. doi: 10.3389/fimmu.2025.1668630. eCollection 2025.ABSTRACTAIMS AND OBJECTIVES: This study aimed to identify immunologically relevant transcriptomic and proteomic biomarkers in hepatocellular carcinoma (HCC) and to characterize their B-cell epitopes for potential integration into nanomaterial-based biosensors and immunomodulatory platforms for early diagnosis and targeted therapy.METHODS: We conducted a comprehensive multi-omics analysis by integrating trans
Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications
Front Immunol. 2025 Oct 14;16:1668630. doi: 10.3389/fimmu.2025.1668630. eCollection 2025.
ABSTRACT
AIMS AND OBJECTIVES: This study aimed to identify immunologically relevant transcriptomic and proteomic biomarkers in hepatocellular carcinoma (HCC) and to characterize their B-cell epitopes for potential integration into nanomaterial-based biosensors and immunomodulatory platforms for early diagnosis and targeted therapy.
METHODS: We conducted a comprehensive multi-omics analysis by integrating transcriptomic (TCGA-LIHC) and proteomic data to identify differentially expressed genes (DEGs) in HCC. Protein-protein interaction networks and pathway enrichment were used to prioritize hub genes. Five candidate biomarkers, RFC2, HSP90AB1, YWHAZ, CYP2E1, and ADH4, were selected for qRT-PCR and serum ELISA validation in clinical cohorts comprising 85 HCC patients and 50 healthy controls. B-cell epitope prediction was performed using BepiPred 2.0 and validated through synthetic peptide-based ELISA in the same cohort to assess immunoreactivity. Diagnostic performance was evaluated using ROC curve analysis.
RESULTS: RFC2, HSP90AB1, and YWHAZ were significantly upregulated (|log2FC|>0.2) and showed high serological expression, whereas CYP2E1 and ADH4 were consistently downregulated. Predicted B-cell epitopes from RFC2, HSP90AB1, and YWHAZ exhibited strong immunoreactivity (AUC>0.84), indicating their diagnostic potential. Enrichment analysis revealed that upregulated DEGs were involved in cell cycle and mitotic progression, while downregulated genes were linked to immune suppression and metabolic dysfunction. These validated immunogenic epitopes offer promising anchors for nanomaterial-functionalized biosensors, such as gold nanoparticle-conjugated ELISA, graphene-based electrochemical platforms, and peptide-coated quantum dots, for ultrasensitive and multiplexed HCC detection.
CONCLUSION: By integrating transcriptomic and proteomic screening with epitope-level validation, we identified a novel panel of immunogenic biomarkers suitable for nanomaterial-enabled diagnostics in HCC. These findings support the translational potential of peptide-nano scaffold conjugates in developing minimally invasive, immune-responsive biosensing and therapeutic tools tailored for early-stage liver cancer management.
PMID:41164201 | PMC:PMC12558944 | DOI:10.3389/fimmu.2025.1668630
-
Nature Biotechnology - Issue - nature.com science feeds
-
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
Nature Biotechnology, Published online: 17 October 2025; doi:10.1038/s41587-025-02845-zThe interactions of CAR-T cells and solid tumors are modeled on a chip.
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
Nature Biotechnology, Published online: 17 October 2025; doi:10.1038/s41587-025-02845-z
The interactions of CAR-T cells and solid tumors are modeled on a chip.-
Journal of Medical Internet Research
-
Diagnostic Performance of Computed Tomography–Based Artificial Intelligence for Early Recurrence of Cholangiocarcinoma: Systematic Review and Meta-Analysis
Background: Despite artificial intelligence (AI) models demonstrating high predictive accuracy for early cholangiocarcinoma recurrence, their clinical application faces challenges, such as reproducibility, generalizability, hidden biases, and uncertain performance across diverse datasets and populations, raising concerns about their practical applicability. Objective: This meta-analysis aims to systematically assess the diagnostic performance of AI models using computed tomography (CT) imaging t
Diagnostic Performance of Computed Tomography–Based Artificial Intelligence for Early Recurrence of Cholangiocarcinoma: Systematic Review and Meta-Analysis
-
Nature Medicine
-
Building the world’s first truly global medical foundation model
Nature Medicine, Published online: 08 September 2025; doi:10.1038/s41591-025-03859-5Building the world’s first truly global medical foundation model
Building the world’s first truly global medical foundation model
Nature Medicine, Published online: 08 September 2025; doi:10.1038/s41591-025-03859-5
Building the world’s first truly global medical foundation model-
Nature - Issue - nature.com science feeds
-
Complex genetic variation in nearly complete human genomes
Nature, Published online: 23 July 2025; doi:10.1038/s41586-025-09140-6Using sequencing and haplotype-resolved assembly of 65 diverse human genomes, complex regions including the major histocompatibility complex and centromeres are analysed.
Complex genetic variation in nearly complete human genomes
Nature, Published online: 23 July 2025; doi:10.1038/s41586-025-09140-6
Using sequencing and haplotype-resolved assembly of 65 diverse human genomes, complex regions including the major histocompatibility complex and centromeres are analysed.-
Cell Death Discovery nature.com science feeds
-
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
Cell Death Discovery, Published online: 24 May 2024; doi:10.1038/s41420-024-02020-4KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
Cell Death Discovery, Published online: 24 May 2024; doi:10.1038/s41420-024-02020-4
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma-
Nature Biotechnology - Issue - nature.com science feeds
-
Scalable, accessible and reproducible reference genome assembly and evaluation in Galaxy
Nature Biotechnology, Published online: 26 January 2024; doi:10.1038/s41587-023-02100-3Scalable, accessible and reproducible reference genome assembly and evaluation in Galaxy
Scalable, accessible and reproducible reference genome assembly and evaluation in Galaxy
Nature Biotechnology, Published online: 26 January 2024; doi:10.1038/s41587-023-02100-3
Scalable, accessible and reproducible reference genome assembly and evaluation in Galaxy-
Nature - Issue - nature.com science feeds
-
A draft human pangenome reference
Nature, Published online: 10 May 2023; doi:10.1038/s41586-023-05896-xAn initial draft of the human pangenome is presented and made publicly available by the Human Pangenome Reference Consortium; the draft contains 94 de novo haplotype assemblies from 47 ancestrally diverse individuals.
A draft human pangenome reference
Nature, Published online: 10 May 2023; doi:10.1038/s41586-023-05896-x
An initial draft of the human pangenome is presented and made publicly available by the Human Pangenome Reference Consortium; the draft contains 94 de novo haplotype assemblies from 47 ancestrally diverse individuals.-
Nature - Issue - nature.com science feeds
-
Semi-automated assembly of high-quality diploid human reference genomes
Nature, Published online: 19 October 2022; doi:10.1038/s41586-022-05325-5Which combination of current genome sequencing and assembly approaches results in high-quality, complete diploid genome assemblies is determined.
Semi-automated assembly of high-quality diploid human reference genomes
Nature, Published online: 19 October 2022; doi:10.1038/s41586-022-05325-5
Which combination of current genome sequencing and assembly approaches results in high-quality, complete diploid genome assemblies is determined.